Rapid Response Partnership Vehicle RFI: Repurposing Equipment for Drug Delivery
About the Rapid Response Partnership Vehicle
The Rapid Response Partnership Vehicle (RRPV) supports the Biomedical Advanced Research and Development Authority (BARDA) in its objective to accelerate Medical Countermeasure (MCM) product and technology development to address evolving needs including pandemic influenza, emerging infectious diseases, and other CBRN threats. It is an agile network of technologists, innovators, traditional contractors, large and small business, academia, and nonprofit research institutions that can respond rapidly and effectively to future pandemic or high consequence biological threats.
Request for Information Description
The objective of this RFI is to solicit feedback from industry, academia, and other stakeholders to assist BARDA in understanding the existing capabilities to assume ownership of available equipment and leverage those assets to manufacture an emergency autoinjector platform, featuring a novel glass-free, collapsible, primary drug container (PDC) with the final intent to develop a new drug delivery device or platform.
Deadline
Submissions are due 23 July 2026 by 1pm ET.